Comparative Studies on the Characteristic Fatty Acid Profiles of Four Different Chinese Medicinal Sargassum Seaweeds by GC-MS and Chemometrics
Overview
Pharmacology
Affiliations
Sargassum seaweeds produce abundant biomass in China and have long been used as herbal medicine and food. Their characteristic fatty acid (FA) profiles and related potential function in promoting cardiovascular health (CVH) have not been systematically investigated. In this study, FA profiles of four medicinal Sargassum were characterized using GC-MS. Principal component analysis was used to discriminate the four medicinal Sargassum, and orthogonal projection to latent structures discriminant analysis was carried out between the two official species HAI ZAO and between the two folk medicine species HAI QIAN. In all of the algae investigated, the major SFA and MUFA were palmitic and stearic acid, respectively, while the major PUFAs were linoleic, arachidonic, and eicosapentaenoic acid. S. fusiforme and S. horneri had higher concentrations of PUFAs. With respect to CVH, all of the studied species, particularly S. fusiforme, exhibited satisfactory levels such as PUFA/SFA ratio and n-6/n-3 ratio. Each species possesses a unique FA profile and is discriminated clearly. Potential key FA markers (between the two Chinese official species, and between the two folk species) are assessed. The study provides characteristic fatty acid profiles of four Chinese medicinal Sargassum and their related potential function in promoting CVH.
Al-Adilah H, Al-Sharrah T, Al-Bader D, Ebel R, Kupper F, Kumari P Foods. 2021; 10(10).
PMID: 34681494 PMC: 8536129. DOI: 10.3390/foods10102442.
Nutritional Indices for Assessing Fatty Acids: A Mini-Review.
Chen J, Liu H Int J Mol Sci. 2020; 21(16).
PMID: 32784511 PMC: 7460856. DOI: 10.3390/ijms21165695.
Giriwono P, Iskandriati D, Tan C, Andarwulan N Mar Drugs. 2019; 17(10).
PMID: 31627414 PMC: 6835611. DOI: 10.3390/md17100590.
Do Different Species of in Haizao Yuhu Decoction Cause Different Effects in a Rat Goiter Model?.
Liu D, Chen F, Yu X, Xiu L, Liu H, Chen S Evid Based Complement Alternat Med. 2019; 2019:5645620.
PMID: 30723515 PMC: 6339761. DOI: 10.1155/2019/5645620.
de Carvalho Rocha W, Schantz M, Sheen D, Chu P, Lippa K Fuel (Lond). 2017; 197:248-258.
PMID: 28603295 PMC: 5464420. DOI: 10.1016/j.fuel.2017.02.025.